DURHAM – Globus Medical has acquired Higgs Boson Health, bringing the Duke-incubated startup’s patient-engagement software and team into the medical-device company’s surgical intelligence business.
Globus announced the acquisition Aug. 26 and described Higgs Boson Health as acquired, not as the subject of a pending agreement. The companies did not disclose financial terms or a separate closing date in Globus Medical’s acquisition announcement or Higgs Boson Health’s follow-up announcement.
Founded in 2017 and incubated at Duke University, Higgs Boson Health developed a digital platform that guides patients through preparation for surgery and recovery. The software also gives care teams information from patients between visits, allowing clinicians to monitor the broader course of care outside the operating room.
Higgs Boson Health said its team is joining Globus Medical and that its technology will become part of Globus’ surgical intelligence operation, connecting patient engagement with outcomes data and analytics. The companies did not say how many employees are moving to Globus, whether the team will remain in Durham or whether the acquisition will result in local hiring or facility changes.
Rajeev Dharmapurikar, Higgs Boson Health’s CEO and co-founder, said in the company’s announcement that joining Globus would give the startup’s technology greater scale. Co-founders Nandan Lad, a Duke professor of neurosurgery, and Ziad Gellad, a Duke professor of medicine, emphasized the role of information collected before and after procedures. Their comments describe the companies’ intended use of the platform, not independently measured results from the acquisition.
The North Carolina Biotechnology Center’s account identifies Higgs Boson Health as one of its portfolio companies. NCBiotech said it provided the startup with a $250,000 Small Business Research Loan in 2019 and another $250,000 loan in 2020 to help improve and market the cloud-based platform then known as Manage My Surgery.
Globus Medical is based in Audubon, Pennsylvania, and develops technology for spine care, orthopedic trauma, joint reconstruction and related procedures. Founder and Executive Chairman David Paul said Higgs Boson Health’s software developers and artificial intelligence scientists would support a broader digital care environment. President and CEO Keith Pfeil said the technology would fit within Globus’ surgical intelligence strategy.
The acquisition gives Globus a Durham-developed platform and the people behind it, but the companies did not disclose the startup’s revenue, acquisition price, workforce size, integration timetable or any financial contribution expected from the deal.
Sources: Globus Medical acquisition announcement: https://www.globenewswire.com/news-release/2026/08/26/3351730/0/en/globus-medical-announces-acquisition-of-higgs-boson-health-to-transform-healthcare-experience-through-ai-driven-digital-solutions.html Higgs Boson Health acquisition announcement: https://www.prweb.com/releases/higgs-boson-health-announces-acquisition-by-globus-medical-302864641.html North Carolina Biotechnology Center report: https://www.ncbiotech.org/news/duke-spinout-higgs-boson-health-acquired Image credit: Company logos courtesy of Higgs Boson Health and Globus Medical.
